Skip to main content

Elmind Capital, LP

SEC CIK
0002052213
Latest filing
Aug 14, 2026

BMRN holding history

Biomarin Pharmaceutical Inc in every 13F filed by Elmind Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BMRN overviewAll 13F holders of BMRNFull Q2 2026 holdings

Shares (Q2 2026)
47,000
Value
$2.69M
% of portfolio
0.7%
Quarters held
3
Since Q4 2025
Holdings of BMRN by Elmind Capital, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202647,000$2.69M0.7%00.0%UnchangedHolders
Q1 202647,000$2.66M0.8%−35,000−42.7%ReducedHolders
Q4 202582,000$4.87M1.4%–No prior filingHolders